广西爱生生命科技有限公司

banner

Company Introduction

AIage is dedicated to translating scientific advances in longevity research into accessible health and longevity products and services.

With the unique centenarian resources from the longevity towns of Guangxi Province, China, our scientist discovered centenarian’s gut microbiome harbors youth-like signatures that protect centenarians from the implications of various aging-related diseases. This landmark discovery paves the path for a novel and proactive approach to tackle aging-related diseases and to promote healthy longevity.

AIage has established a centenarian-derived bacterial bank with more identified 50,000 strains. Collaborating with the world’s leading scientists and physicians, We develop a full load of clinically validated products to address metabolic diseases, chronic inflammation, oxidative stress, sleep or anxiety disorder and other aging problems.

Management Team

200 200 ⁺

More than 200 employees

40 40 ^%

R&D personnel ratio

41 41 ^%

Graduate student ratio

10 10 ⁺

Intermediate and above professional and technical talents

30 30 ⁺

Health Manager

Mr. Zuoquan Xia Honorary Chairman

Mr. Xia is the honorary chairman of AIage and the chairman of Zhengxuan Investment. As an angel investor, co-founder, and director of BYD, he’s also an early investor in AIage. Mr. Xia has invested in over 200 companies across diverse sectors: aerospace, semiconductors, advanced manufacturing, information technology, supply -chain AI, new energy, new materials, biomedicine, and longevity technology. The total value of assets he manages approaches ¥100 billion.

Dr. Zhong Kuang Chairman of the Board

Dr. Zhong Kuang, founder and chairman of AIage, earned his doctorate in finance from the Chinese Academy of Social Sciences. He serves as a Distinguished Research Fellow of the 50 People Forumon Healthy China and president of the Longevity Engineering Branch of the Chinese Anti -Aging Promotion Association. Armed with extensive international investment and corporate management experience, he has invested in nearly 200 projects across various sectors. His investment portfolio includes UBTECH(HK9880), Enlight Media (300251.SZ), Huayi Brothers(300027.SZ), Axonics(listed on NASDAQ), QloudX(quantumcomputing), AIage Life Sciences(longevity tech), One Space(rockets), and BGI Genomics(genetics). Many of these portfolio companies have gone public. Dr. Kuang has received multiple provincial and ministerial-level economic awards. Notably, he wasamongthe first to propose research on the Asian Infrastructure Investment Bank(AIIB). Proficient in conducting breakthrough and paradigm -shifting innovation research and applying advanced investment strategies, he stands out as a prominent Chinese entrepreneur and venture capitalist.

Mr. Xiaodong Chen Chief Policy Development Officer

Mr. Chen is theco-founder and Chief Policy Development Officer of AIage. Additionally, he serves as the vice president of the Guangxi Longevity Industry Development Promotion Association. He holds an MPA from the School of Government at Peking University. Previously, he worked as the deputy head of Qingxiu Districtin Nanning. He also served as the general manager of CIMC Cloud Entrepreneurship Industrial Park Investment Company and the CEO of the Google Guangxi Experience Center. Well-versed in industrial operation and startup project management, he has hands-on experience in frontier fields such as cross-bordere-commerce, AI, IoT, and biomedicine.

Mr. Shan Kuang Vice President

Mr. Kuang serves as the vice president of AIage and heads the AIage Intelligence Longevity Factory. Graduating with an EMBA in Business Administration from Guangxi University, he also functions as the chief supervisor of the Guangxi Drinking Water Industry Association. He co-founded several food enterprises. Notable among them are Guangxi’s renowned mineral water brand“90 Million”and the beer and beverage brand “Fresh Beer 100”. Proficient in production and construction processes, he has amassed over 20 years of experience in managing food production systems and ensuring quality control.

Mr. Yun Ling Vice President

Mr. Ling serves as the vice president of AIage, the chairman of Guangxi AIage Clinic Co., Ltd., and the deputy secretary -general of the Longevity Engineering Branch of the Chinese Anti -Aging Promotion Association. Analumnus of Peking University, he holds a bachelor's degree in International Law and an EMBA from Peking University's Guanghua School of Management. He has worked at the China Council for the Promotion of International Trade Guangxi Sub -council, Guangxi Import and Export Trading Co., Ltd., and Meinian Health care Group. He has accumulated rich theoretical and practical experience in international trade, project investment &M&A, general health management, and corporate ecosystem operation and management.

Development History

2024

AIage appointed as the presiding unit of the Longevity Engineering Branch of the Chinese Anti-Aging Promotion Association.
AIage partnered with China Life Insurance Nanning Branch to co-establish the "China Life Longevity Home."
AIage collaborated with Qianhai Life Insurance Nanning Hospital to establish a Gut Microbiota Transplantation Center and an Anti-Aging Clinic.
AIage signed an investment cooperation agreement for the Northern Longevity Technology Center (with a total project investment of 2 billion CNY) in Weifang, Shandong.
AIage invested in and opened the nation's first comprehensive longevity clinic.
AIage's Western Longevity Technology Center, a production facility with an annual capacity worth hundreds of millions, successfully obtained its food production license and commenced operations.
Three of AIage's longevity technology research achievements were published in top international journals.
AIage's longevity technology products were designated as "Recommended Products at the International Expo Celebrating the 31st Anniversary of the Commonwealth."

2023

AIage's significant scientific research achievements on human longevity indicators have been published for the first time in the international top journal Nature's sub-journal.
AIage has signed an industrial investment project cooperation agreement with the Tongchuan District Government.
The Guangxi Longevity Science and Technology Key Laboratory, established with the support of AIage, has been approved.

2022

AIage signed a contract with Nanning Industrial Investment, with a total investment of ¥2.25 billion.
AIage signed a contract with the First Affiliated Hospital of Guangxi Medical University to carry out medical clinical and industrial research and transformation research.

2021

Established a strategic cooperative relationship with the China Science Center of the International Eurasian Academy of Sciences.
It has been recognized as a national high-tech enterprise.

2020

Establish a global super longevity database.
Co-establish the Nanning Longevity Science and Technology New Industry Technology Research Institute with the Nanning Municipal Bureau of Science and Technology.

2019

AIage and Fudan University jointly established the Fudan University Key Laboratory of Modern Anthropology Education Department Guangxi Research Base.
Cooperated with the First Affiliated Hospital of Guangxi Medical University to carry out clinical research on more than 2,000 cases.

2018

Launch the Super Longevity Human Microbiome Project.
Conduct data sample analysis and research on over 100,000 longevity cohort cases.

2017

AIage Life Science Co., Ltd. was registered and established.

Five Advantages

Future Longevity Technology Industry

Advantages of Longevity Big Data

200,000+ cases of longevity and cohort population data collection research.
Separately screened out tens of thousands of functional strains from the source of longevity people.
Established the world's largest longevity resource database and core strain bank of longevity people.

Track and Industry Leadership Advantage

The 'Silver Tsunami' sweeps across the globe, with the future global health and longevity market scale reaching 17.5 trillion US dollars. Delaying aging by one year can bring economic benefits of $38 trillion. AIage has been deeply engaged in the longevity industry for many years and is now a pioneer in the longevity technology sector.

Resource Acquisition Advantage

Headquartered in China's most abundant area of longevity resources—Guangxi.
The first provincial-level long life science and technology key laboratory in China.
The initiator and leading unit of China's first Longevity Engineering Professional Platform.

Talent Advantage

With a top-tier interdisciplinary research and development team at its core. Including Nobel Prize in Physiology or Medicine team members, postdoctoral fellows from the University of Pennsylvania, top experts in big data fields at Tsinghua University, and other professional talent.

Alage Life Science company 202506_05.png

Technical Accumulation Advantage

The world's first longevity technology achievement industrial transformation base, centered on longevity technology, has developed an integrated 'prevention-screening-intervention' longevity management plan. Establish eight major industry centers of 'R&D, production, application, brand, and operation', global layout of longevity industry cluster.

Seven MajorIndustries

Weifang,Shandong(Under Construction)

Shenzhen, Guangdong

Shenzhen AIage Longevity Technology Co., Ltd.

Longevity Tech Operations Center

Nanning, Guangxi

AIage Life Science Co., Ltd.

Longevity Science R&D Center，Longevity Core Database & Stain Bank，LMT Center

Dazhou, Sichuan

Sichuan AIage Life Science Co., Ltd

Longevity Tech Manufacturing Center，SW Longevity Industry incubation & Transformation Base

Wuhan, HuBei

Aimeiyinian(Wuhan) Life Science & Health Technology Co., Ltd

The Joint venture of AIage and Meinian Healthcare Croup，Gut Microbiome based Health Management Proje

Shanghai

Shanghai AIage Life Science Co., Ltd

Longevity Ecological Operation Center

Changsha,Hunan

Hunan AIage Life Science Co.,Ltd

Longevity Ecological Cooperation Operation Center

Jingping, Yunnan

Yunan AIage Life Science Co., Ltd

Longevity Industry incubation & Transformation Base

Based on the world's leading R&D achievements in longevity technology, we have subsequently established 8 distributed longevity industry institutions centered on R&D, production, application, branding, operation and other basic functional units of longevity technology productization, moreover, it has developed new products with professional capabilities and is able to provide customers with high-quality products. As the world’s premier industrial transformation base for longevity technology R&D achievements, AIage Intelligence Longevity Factory is managed by a premier longevity technology research and product development team, Consequently, it has achieved normalized and large-scale production.

The company has comprehensively strengthened its management and successively passed the ISO9001: 2015 Quality Management System, ISO14001: 2015 Environmental Management System, and ISO45001: 2018 Occupational Health and Safety Management System certification.
In the future, AIage will establish more longevity industry clusters in China.

Honors

Over 100 national invention patents and software copyrights

Governing Unit of China Anti-Aging Promotion Association
President of the Longevity Project Branch of China Anti-Aging Promotion Association
Governing Unit of China Association of Gerontology and Health Care
Guangxi Longevity Science and Technology Key Laboratory
Vice President Unit of Guangxi Longevity Industry Development Promotion Association
Vice President unit of Guangxi Anti-aging Science and Technology Society
......

Lead Organization for the Group Standard "Evaluation Methods for the Efficacy of Functional Foods in Supporting Healthy

Lead Drafting Unit for the Group Standard "Test Methods for Efficacy in Intestinal Health Improvement”

Specialized, New and Innovative SMEs

Director Unit of China Health Care Association for the Aged

Governing Board Member Unit of China Anti-Aging Promotion Association

China Private Medical Institution Association Member Units

Ageing Health Science Popularization Base

Recommendations for the 31st Anniversary of the Commonwealth International Expo

Nanning Longevity Technology New Industry Technology Research Institute

Nanning Digital Polymerase Chain Reaction Engineering Technology Research Center

New R&D institutions in Guangxi Zhuang Autonomous Region

Guangxi Key Laboratory of Longevity Science and Technology

Gastrointestinal Microecology Diagnosis and Treatment Center

GXU of Medicine Industry-Academia-Research-Application Longevity Science and Technology Collaborative Technology Center

FDU of Life Sciences Key Laboratory for Modern Anthropology Education Department Guangxi Research Base

2024 Southeast Asia Emerging Future Unicorn TOP100

CCTV Great Nation's Craftsmanship Program Longevity Technology Industry Partner

2024 Southeast Asia
New Overseas Future Unicorns

High-tech enterprise

China Anti-Aging Promotion Association Longevity Project Branch